Our results revealed a significant negative correlation between the endogenous levels of miR-155-5p and mRNA BRCA1 within WBC for patients with breast and ovarian cancer and BRCA1-methylation carriers, which is not the case in controls. This evidence concerns the gene BRCA1 and ovarian carcinoma.